title: The EGFR family members sustain the neoplastic phenotype of ALK+ lung adenocarcinoma via EGR1.
abstract: In non-small cell lung cancer (NSCLC), receptor tyrosine kinases (RTKs) stand out among causal dominant oncogenes, and the ablation of RTK signaling has emerged as a novel tailored therapeutic strategy. Nonetheless, long-term RTK inhibition leads invariably to acquired resistance, tumor recurrence and metastatic dissemination. In ALK+ cell lines, inhibition of ALK signaling was associated with coactivation of several RTKs, whose pharmacological suppression reverted the partial resistance to ALK blockade. Remarkably, ERBB2 signaling synergized with ALK and contributed to the neoplastic phenotype. Moreover, the engagement of wild-type epidermal growth factor receptor or MET receptors could sustain cell viability through early growth response 1 (EGR1) and/or Erk1/2; Akt activation and EGR1 overexpression prevented cell death induced by combined ALK/RTK inhibition. Membrane expression of ERBB2 in a subset of primary naive ALK+ NSCLC could be relevant in the clinical arena. Our data demonstrate that the neoplastic phenotype of ALK-driven NSCLC relays 'ab initio' on the concomitant activation of multiple RTK signals via autocrine/paracrine regulatory loops. These findings suggest that molecular and functional signatures are required in de novo lung cancer patients for the design of efficacious and multi-targeted 'patient-specific' therapies.
authors.affiliation: 1] Department of Biomedical Sciences and Human Oncology, Center for Experimental Research and Medical Studies (CERMS), University of Torino, Torino, Italy [2] Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy.
authors.forename: C
authors.initials: C
authors.lastname: Voena
authors.forename: F
authors.initials: F
authors.lastname: Di Giacomo
authors.forename: E
authors.initials: E
authors.lastname: Panizza
authors.forename: L
authors.initials: L
authors.lastname: D'Amico
authors.forename: F E
authors.initials: FE
authors.lastname: Boccalatte
authors.forename: E
authors.initials: E
authors.lastname: Pellegrino
authors.forename: M
authors.initials: M
authors.lastname: Todaro
authors.forename: D
authors.initials: D
authors.lastname: Recupero
authors.forename: F
authors.initials: F
authors.lastname: Tabbò
authors.forename: C
authors.initials: C
authors.lastname: Ambrogio
authors.forename: C
authors.initials: C
authors.lastname: Martinengo
authors.forename: L
authors.initials: L
authors.lastname: Bonello
authors.forename: R
authors.initials: R
authors.lastname: Pulito
authors.forename: J
authors.initials: J
authors.lastname: Hamm
authors.forename: R
authors.initials: R
authors.lastname: Chiarle
authors.forename: M
authors.initials: M
authors.lastname: Cheng
authors.forename: B
authors.initials: B
authors.lastname: Ruggeri
authors.forename: E
authors.initials: E
authors.lastname: Medico
authors.forename: G
authors.initials: G
authors.lastname: Inghirami